Clin2
NCT06667245Likely a fitNot yet recruiting

Shingles vaccine and quality of life

Herpes ZosterQuality of LifeImmunization; Infection

Part of Infections clinical trials.

This study is looking at how getting the shingles vaccine affects your quality of life and the overall burden of the disease. Researchers will track your health over time to understand what life is like after vaccination versus not.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
357 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be 18 or older
  • You must be planning to get the shingles vaccine
  • You cannot be pregnant
  • You must be able to fill out questionnaires about your health

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07481604Not yet recruiting· Phase 2
Shingles vaccine study for adults 50 and older

This study tests a new vaccine to prevent shingles (a painful rash condition) in adults 50 and older. It checks how safe the vaccine is and how well it triggers the body's immune defense.

Daegu, Daegu
NCT07205796Not yet recruiting· Phase 2
mRNA vaccine to prevent shingles in adults aged 50 to 79

This trial is testing an experimental mRNA vaccine for preventing shingles. It aims to see if the vaccine is safe and triggers a good immune response in people aged 50 to 79.

NCT07354659Not yet recruiting· Phase 2
Shingles vaccine study for adults 40 and older

This study tests an investigational vaccine (SYS6017) to see how well it works and if it's safe for adults 40 and older. The vaccine aims to prevent shingles, a painful rash caused by the same virus as chickenpox.

NCT06954818Not yet recruiting· Phase 1
Safety study of a new shingles vaccine

This trial tests a new investigational shingles vaccine to see if it is safe and produces an immune response in healthy adults 40 and older. Participating could help protect against shingles and its complications.

NCT06088745Recruiting· Phase 3
Shingles vaccine trial for adults 40+

This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.

Zhenjiang, Jiangsu
NCT07400003Recruiting· Phase 1/Phase 2
Shingles mRNA vaccine safety and immune response study

This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).

Xinjiang

Hear when a new Herpes Zoster trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.